Enhancing anti-fibrotic therapy: nanomedicine approaches to overcome current limitations
Lincan Wu, Xin Li, Lina Yang · 2026
Read Enhancing anti-fibrotic therapy: nanomedicine approaches to overcome current limitations by Lincan Wu, Xin Li, Lina Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13241989.txt.
Description
Wu, Li, and Yang reviewed nanomedicine for fibrosis in this paper from twenty twenty-six. Fibrosis, the scarring of tissue, runs through many chronic diseases. Drugs against it often miss the target tissue, cause side effects, or absorb poorly. Tiny engineered particles offer two ways around those limits.
First, nanoparticles can ferry drugs straight to scarred tissue and release them in a controlled way. Second, some nanomaterials ease fibrosis by their own action, with no cargo at all. The review sorts designs and materials by the organs they treat. It weighs what each approach has achieved in the lab and clinic so far. The authors frame nanotechnology as a reset for a stalled treatment field.
Catalog record
| CREATOR | Lincan Wu, Xin Li, Lina Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 126 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |